Henry Schein Inc (HSIC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 27 2026 to Jun 28 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Henry Schein Inc   (NASDAQ: HSIC)


Henry Schein Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Henry Schein Inc's ROI in the second quarter of 2026?
Henry Schein Inc achieved a return on average invested assets (ROI) of 5.31 % in its second quarter of 2026, which is below Henry Schein Inc's average return on investment, which stands at 10.43%.

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector 143 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1529 to 1565.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 27 2026)
II. Quarter		 (Mar 28 2026)
I. Quarter		 (Dec 27 2025)
IV. Quarter		 (Sep 27 2025)
III. Quarter		 (Jun 28 2025)
II. Quarter
Y / Y Investment Change TTM 7.03 % 9.72 % 8.84 % 3.69 % 1.12 %
Y / Y Net Income Change TTM 5.97 % 1.21 % 39.67 % 101.96 % 282.86 %
Investment (TTM) in Millions 7,893 8,085 8,065 8,029 7,980
Return On Investment (TTM) 5.31 % 5.2 % 5.28 % 5.37 % 5.37 %
HSIC's Overall Ranking # 1565 # 1529 # 1154 # 1141 # 869
Seq. Investment Change TTM -0.27 % 1.4 % 3.29 % 2.46 % 2.23 %
Seq. Net Income Change TTM 1.91 % -0.24 % 1.7 % 2.49 % -2.66 %
Net Income (TTM) in Millions 426 418 419 412 402

HSIC Company Profile >> Back to HSIC Roi Comparisons >> See Annual HSIC Return On Investment



Return On Investment HSIC's Ranking
Within: No.
Industry # 42
Sector # 144
Overall # 1565

Return On Investment Statistics
High Average Low
14.83 %
10.43 %
4.11 %
(Jul 01 2017)   (Sep 28 2024)







Financial Statements
Henry Schein Inc's II. Quarter Investments $ 7,893 Millions HSIC's Balance sheet
Henry Schein Inc's II. Quarter Income $ 102 Millions Quarterly HSIC's Income Statement
HSIC's Income by Division See HSIC's Income by Division


HSIC Annual Return On Investment (Dec 27 2025)
2025		 (Dec 28 2024)
2024		 (Dec 30 2023)
2023		 (Dec 31 2022)
2022		 (Dec 25 2021)
2021
Total Investments in Millions 7,590 7,054 7,526 6,072 5,865
Y / Y Investment Growth 7.6 % -6.27 % 23.95 % 3.54 % 12.33 %
Net Income in Millions 419 398 436 566 661
Y / Y Net Income Growth 5.28 % -8.72 % -22.97 % -14.31 % 57.48 %
Annual Return On Investment 5.52 % 5.64 % 5.79 % 9.32 % 11.26 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 5.52 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HSIC's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HSIC's Competitors
Subscribers only: Roi for Henry Schein Inc's Suppliers
Subscribers only: Return On Investment for HSIC's Customers

Other Ratios
HSIC's Roa HSIC's Inventory Turnover Ratio HSIC's Growth Rates HSIC's Dividend Statistics
HSIC's Profitability Ratios HSIC's Asset Turnover Ratio HSIC's Dividend Growth
HSIC's Roe HSIC's Valuation Ratios HSIC's Financial Strength Ratios HSIC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 27 2026, within Healthcare Sector ROI
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %
Lemaitre Vascular Inc   11.20 %
3m Company  11.16 %
Globus Medical Inc   11.01 %
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %

Date modified: 2026-09-26T07:16:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.